Merck & Co. PT Raised to $62.00 at BMO Capital Markets (MRK)
BMO Capital Markets boosted their price target on shares of Merck & Co. (NYSE:MRK) from $60.00 to $62.00 in a research note issued on Thursday. BMO Capital Markets’ price objective would suggest a potential upside of 9.15% from the stock’s previous close.
MRK has been the subject of a number of other recent research reports. Analysts at Mainfirst upgraded shares of Merck & Co. from an “underperform” rating to an “outperform” rating in a research note on Monday, July 28th. Separately, analysts at Leerink Swann raised their price target on shares of Merck & Co. from $57.00 to $60.00 in a research note on Tuesday, July 8th. Finally, analysts at Citigroup Inc. raised their price target on shares of Merck & Co. from $44.00 to $57.00 in a research note on Monday, July 7th. They now have a “neutral” rating on the stock. Six analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Merck & Co. presently has an average rating of “Buy” and a consensus target price of $60.57.
Shares of Merck & Co. (NYSE:MRK) traded up 0.11% during mid-day trading on Thursday, hitting $56.80. 10,140,975 shares of the company’s stock traded hands. Merck & Co. has a 1-year low of $44.62 and a 1-year high of $59.84. The stock has a 50-day moving average of $58.21 and a 200-day moving average of $56.46. The company has a market cap of $166.0 billion and a price-to-earnings ratio of 29.89.
Merck & Co. (NYSE:MRK) last released its earnings data on Tuesday, July 29th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.05. The company had revenue of $10.93 billion for the quarter, compared to the consensus estimate of $10.60 billion. During the same quarter in the previous year, the company posted $0.84 earnings per share. The company’s revenue for the quarter was down .7% on a year-over-year basis. Analysts expect that Merck & Co. will post $3.49 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, October 7th. Stockholders of record on Monday, September 15th will be paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 3.10%. The ex-dividend date is Thursday, September 11th.
Merck & Co, Inc (NYSE:MRK), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures.
Receive News & Ratings for Merck & Co Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck & Co Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.